153 related articles for article (PubMed ID: 30129678)
1. FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway.
Toeda Y; Kasamatsu A; Koike K; Endo-Sakamoto Y; Fushimi K; Kasama H; Yamano Y; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2018 Dec; 57(12):1690-1697. PubMed ID: 30129678
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2b receptor promotes progression of human oral cancer.
Kasama H; Sakamoto Y; Kasamatsu A; Okamoto A; Koyama T; Minakawa Y; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
BMC Cancer; 2015 Jul; 15():563. PubMed ID: 26228921
[TBL] [Abstract][Full Text] [Related]
4. Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
Koide N; Kasamatsu A; Endo-Sakamoto Y; Ishida S; Shimizu T; Kimura Y; Miyamoto I; Yoshimura S; Shiiba M; Tanzawa H; Uzawa K
Sci Rep; 2017 Feb; 7():43379. PubMed ID: 28230172
[TBL] [Abstract][Full Text] [Related]
5. Cavin-2 in oral cancer: A potential predictor for tumor progression.
Unozawa M; Kasamatsu A; Higo M; Fukumoto C; Koyama T; Sakazume T; Nakashima D; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2016 Jun; 55(6):1037-47. PubMed ID: 26086332
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated sodium channel Nav1.5 promotes proliferation, migration and invasion of oral squamous cell carcinoma.
Zhang J; Mao W; Dai Y; Qian C; Dong Y; Chen Z; Meng L; Jiang Z; Huang T; Hu J; Luo P; Korner H; Jiang Y; Ying S
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):562-570. PubMed ID: 31139826
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
9. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
10. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
11. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Yamamoto T
J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
[TBL] [Abstract][Full Text] [Related]
12. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
13. Tspan15 plays a crucial role in metastasis in oral squamous cell carcinoma.
Hiroshima K; Shiiba M; Oka N; Hayashi F; Ishida S; Fukushima R; Koike K; Iyoda M; Nakashima D; Tanzawa H; Uzawa K
Exp Cell Res; 2019 Nov; 384(2):111622. PubMed ID: 31518558
[TBL] [Abstract][Full Text] [Related]
14. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
Dai J; Wei W
Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
[TBL] [Abstract][Full Text] [Related]
15. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
Shimizu T; Kasamatsu A; Yamamoto A; Koike K; Ishige S; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas.
Hiraishi Y; Wada T; Nakatani K; Negoro K; Fujita S
Pathol Oncol Res; 2006; 12(2):87-91. PubMed ID: 16799709
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Oral Squamous Cell Carcinoma Proliferation Through Crosstalk Between SMAD7 and CYLD.
Ge WL; Xu JF; Hu J
Cell Physiol Biochem; 2016; 38(3):1209-17. PubMed ID: 26982322
[TBL] [Abstract][Full Text] [Related]
18. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
[TBL] [Abstract][Full Text] [Related]
19. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]